Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Targeted left ventricular lead positioning to the site of latest activation in cardiac resynchronization therapy: a systematic review and meta-analysis

DB. Fyenbo, HL. Bjerre, MHJP. Frausing, C. Stephansen, A. Sommer, R. Borgquist, Z. Bakos, M. Glikson, A. Milman, R. Beinart, R. Kockova, K. Sedlacek, D. Wichterle, S. Saba, S. Jain, A. Shalaby, MB. Kronborg, JC. Nielsen

. 2023 ; 25 (9) : . [pub] 2023Aug02

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu metaanalýza, systematický přehled, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23016619

Grantová podpora
Aarhus University
R140-A9482-B2407 Danish Heart Foundation
R64-A3194-B1667 Health Research Foundation of Central Denmark Region
Gangstedfonden
PhD2021011-HF Danish Cardiovascular Academy

AIMS: Several studies have evaluated the use of electrically- or imaging-guided left ventricular (LV) lead placement in cardiac resynchronization therapy (CRT) recipients. We aimed to assess evidence for a guided strategy that targets LV lead position to the site of latest LV activation. METHODS AND RESULTS: A systematic review and meta-analysis was performed for randomized controlled trials (RCTs) until March 2023 that evaluated electrically- or imaging-guided LV lead positioning on clinical and echocardiographic outcomes. The primary endpoint was a composite of all-cause mortality and heart failure hospitalization, and secondary endpoints were quality of life, 6-min walk test (6MWT), QRS duration, LV end-systolic volume, and LV ejection fraction. We included eight RCTs that comprised 1323 patients. Six RCTs compared guided strategy (n = 638) to routine (n = 468), and two RCTs compared different guiding strategies head-to-head: electrically- (n = 111) vs. imaging-guided (n = 106). Compared to routine, a guided strategy did not significantly reduce the risk of the primary endpoint after 12-24 (RR 0.83, 95% CI 0.52-1.33) months. A guided strategy was associated with slight improvement in 6MWT distance after 6 months of follow-up of absolute 18 (95% CI 6-30) m between groups, but not in remaining secondary endpoints. None of the secondary endpoints differed between the guided strategies. CONCLUSION: In this study, a CRT implantation strategy that targets the latest LV activation did not improve survival or reduce heart failure hospitalizations.

000      
00000naa a2200000 a 4500
001      
bmc23016619
003      
CZ-PrNML
005      
20231026105656.0
007      
ta
008      
231013s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/europace/euad267 $2 doi
035    __
$a (PubMed)37695316
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Fyenbo, Daniel Benjamin $u Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark $u Department of Clinical Medicine, Aarhus University, Palle Juul-Jensens Boulevard 11, 8200 Aarhus N, Denmark $u Diagnostic Center, Silkeborg Regional Hospital, Falkevej 1A, 8600 Silkeborg, Denmark $1 https://orcid.org/0000000158981743
245    10
$a Targeted left ventricular lead positioning to the site of latest activation in cardiac resynchronization therapy: a systematic review and meta-analysis / $c DB. Fyenbo, HL. Bjerre, MHJP. Frausing, C. Stephansen, A. Sommer, R. Borgquist, Z. Bakos, M. Glikson, A. Milman, R. Beinart, R. Kockova, K. Sedlacek, D. Wichterle, S. Saba, S. Jain, A. Shalaby, MB. Kronborg, JC. Nielsen
520    9_
$a AIMS: Several studies have evaluated the use of electrically- or imaging-guided left ventricular (LV) lead placement in cardiac resynchronization therapy (CRT) recipients. We aimed to assess evidence for a guided strategy that targets LV lead position to the site of latest LV activation. METHODS AND RESULTS: A systematic review and meta-analysis was performed for randomized controlled trials (RCTs) until March 2023 that evaluated electrically- or imaging-guided LV lead positioning on clinical and echocardiographic outcomes. The primary endpoint was a composite of all-cause mortality and heart failure hospitalization, and secondary endpoints were quality of life, 6-min walk test (6MWT), QRS duration, LV end-systolic volume, and LV ejection fraction. We included eight RCTs that comprised 1323 patients. Six RCTs compared guided strategy (n = 638) to routine (n = 468), and two RCTs compared different guiding strategies head-to-head: electrically- (n = 111) vs. imaging-guided (n = 106). Compared to routine, a guided strategy did not significantly reduce the risk of the primary endpoint after 12-24 (RR 0.83, 95% CI 0.52-1.33) months. A guided strategy was associated with slight improvement in 6MWT distance after 6 months of follow-up of absolute 18 (95% CI 6-30) m between groups, but not in remaining secondary endpoints. None of the secondary endpoints differed between the guided strategies. CONCLUSION: In this study, a CRT implantation strategy that targets the latest LV activation did not improve survival or reduce heart failure hospitalizations.
650    _2
$a lidé $7 D006801
650    12
$a srdeční resynchronizační terapie $x škodlivé účinky $7 D058406
650    _2
$a echokardiografie $7 D004452
650    12
$a srdeční selhání $x diagnóza $x terapie $7 D006333
650    _2
$a srdeční komory $x diagnostické zobrazování $7 D006352
650    _2
$a hospitalizace $7 D006760
655    _2
$a metaanalýza $7 D017418
655    _2
$a systematický přehled $7 D000078182
655    _2
$a časopisecké články $7 D016428
700    1_
$a Bjerre, Henrik Laurits $u Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark $u Department of Clinical Medicine, Aarhus University, Palle Juul-Jensens Boulevard 11, 8200 Aarhus N, Denmark $1 https://orcid.org/0009000487673669
700    1_
$a Frausing, Maria Hee Jung Park $u Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark $u Department of Clinical Medicine, Aarhus University, Palle Juul-Jensens Boulevard 11, 8200 Aarhus N, Denmark $1 https://orcid.org/0000000320261032
700    1_
$a Stephansen, Charlotte $u Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark $1 https://orcid.org/0000000332722115
700    1_
$a Sommer, Anders $u Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark
700    1_
$a Borgquist, Rasmus $u Arrhythmia Section, Skaane University Hospital, Lund, Sweden $1 https://orcid.org/0000000213656637
700    1_
$a Bakos, Zoltan $u Department of Cardiology, Kristianstad Hospital, Kristianstad, Sweden $1 https://orcid.org/0000000172083317
700    1_
$a Glikson, Michael $u Jesselson Integrated Heart Center, Shaare Zedek Medical Center, Jerusalem, Israel $u Faculty of Medicine, Hebrew University, Jerusalem, Israel $1 https://orcid.org/0000000157060395
700    1_
$a Milman, Anat $u Leviev Heart Institute, The Chaim Sheba Medical Center, Tel Hashomer, Israel $u Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel $1 https://orcid.org/0000000285514101
700    1_
$a Beinart, Roy $u Leviev Heart Institute, The Chaim Sheba Medical Center, Tel Hashomer, Israel $u Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel $1 https://orcid.org/0000000292684766
700    1_
$a Kockova, Radka $u Department of Cardiac Surgery, Na Homolce Hospital, Prague, Czech Republic $1 https://orcid.org/0000000266450245
700    1_
$a Sedlacek, Kamil $u 1st Department of Internal Medicine-Cardiology and Angiology, University Hospital, Hradec Králové, Czech Republic $u Faculty of Medicine, Charles University, Hradec Králové, Czech Republic $1 https://orcid.org/0000000312571321
700    1_
$a Wichterle, Dan $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $1 https://orcid.org/0000000204485143 $7 xx0101417
700    1_
$a Saba, Samir $u Heart and Vascular Institute, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA $1 https://orcid.org/000000034669803X
700    1_
$a Jain, Sandeep $u Heart and Vascular Institute, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
700    1_
$a Shalaby, Alaa $u Heart and Vascular Institute, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA $1 https://orcid.org/0000000220007678
700    1_
$a Kronborg, Mads Brix $u Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark $u Department of Clinical Medicine, Aarhus University, Palle Juul-Jensens Boulevard 11, 8200 Aarhus N, Denmark $1 https://orcid.org/000000031672222X
700    1_
$a Nielsen, Jens Cosedis $u Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark $u Department of Clinical Medicine, Aarhus University, Palle Juul-Jensens Boulevard 11, 8200 Aarhus N, Denmark $1 https://orcid.org/0000000194141653
773    0_
$w MED00149837 $t Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology $x 1532-2092 $g Roč. 25, č. 9 (2023)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37695316 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026105651 $b ABA008
999    __
$a ok $b bmc $g 2000250 $s 1202981
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 25 $c 9 $e 2023Aug02 $i 1532-2092 $m Europace $n Europace $x MED00149837
GRA    __
$p Aarhus University
GRA    __
$a R140-A9482-B2407 $p Danish Heart Foundation
GRA    __
$a R64-A3194-B1667 $p Health Research Foundation of Central Denmark Region
GRA    __
$p Gangstedfonden
GRA    __
$a PhD2021011-HF $p Danish Cardiovascular Academy
LZP    __
$a Pubmed-20231013

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...